Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

PC-PLD2C Inhibitors

PC-PLD2C inhibitors represent a specialized class of chemical compounds that specifically target the enzyme phospholipase D2 (PLD2), which is one of the key isoforms within the phospholipase D (PLD) enzyme family. PLD enzymes play a crucial role in cellular lipid metabolism by catalyzing the hydrolysis of phosphatidylcholine (PC) to generate phosphatidic acid (PA) and choline. PLD2, in particular, is predominantly associated with signal transduction pathways that regulate various cellular processes, including membrane trafficking, cytoskeletal reorganization, and cell proliferation. PC-PLD2C inhibitors function by selectively binding to the active site or allosteric sites of PLD2, thereby obstructing its catalytic activity. This inhibition is significant in research contexts where modulation of lipid signaling pathways is necessary to understand the fundamental biochemical and cellular mechanisms mediated by PLD2 activity.

Chemically, PC-PLD2C inhibitors encompass a diverse array of structural classes, ranging from small molecules to more complex organic compounds. These inhibitors are designed through meticulous structural modifications aimed at achieving high specificity and affinity for PLD2 over other PLD isoforms and unrelated enzymes. The structural diversity among these inhibitors allows for fine-tuning of their physicochemical properties, such as solubility, stability, and membrane permeability, which are critical for their effectiveness in various experimental setups. Advanced techniques in computational chemistry, such as molecular docking and dynamics simulations, are often employed to predict and optimize the interaction of these inhibitors with PLD2 at the atomic level. Additionally, synthetic organic chemistry plays a vital role in the iterative process of synthesizing and refining these compounds, enabling researchers to develop inhibitors with enhanced potency and selectivity. The study and development of PC-PLD2C inhibitors thus provide invaluable insights into the intricate network of lipid signaling pathways, facilitating a deeper understanding of cellular physiology and biochemistry.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluoxetine

54910-89-3sc-279166
500 mg
$312.00
9
(1)

Fluoxetine inhibits PC-PLD2C by interfering with serotonin reuptake, potentially disrupting downstream signaling pathways involved in its activation or regulation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin inhibits PC-PLD2C by targeting phosphoinositide 3-kinase (PI3K), a key regulator of PLD activity, thus indirectly impacting its function in cellular signaling pathways.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

Haloperidol inhibits PC-PLD2C by blocking dopamine receptors, which may lead to downstream effects on PLD activation or regulation within intracellular signaling cascades.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol inhibits PC-PLD2C by antagonizing β-adrenergic receptors, potentially influencing PLD activity through modulation of downstream signaling pathways.

Rottlerin

82-08-6sc-3550
sc-3550B
sc-3550A
sc-3550C
sc-3550D
sc-3550E
10 mg
25 mg
50 mg
1 g
5 g
20 g
$82.00
$163.00
$296.00
$2050.00
$5110.00
$16330.00
51
(2)

Rottlerin inhibits PC-PLD2C by targeting protein kinase C (PKC), a known regulator of PLD activity, thus indirectly affecting its function in cellular signaling pathways.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

Suramin inhibits PC-PLD2C by interfering with various growth factor receptors and downstream signaling pathways, potentially modulating PLD activity in response to extracellular signals.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 inhibits PC-PLD2C by targeting Rho-associated protein kinase (ROCK), which plays a role in PLD activation and regulation, thus influencing its function in cellular signaling.

Ginkgolide B

15291-77-7sc-201037B
sc-201037
sc-201037C
sc-201037A
5 mg
10 mg
25 mg
50 mg
$45.00
$63.00
$112.00
$197.00
8
(1)

Ginkgolide B inhibits PC-PLD2C by interfering with calcium channels or phosphodiesterase activity, potentially modulating PLD function through calcium-mediated signaling pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059 inhibits PC-PLD2C by targeting mitogen-activated protein kinase kinase (MEK), which regulates PLD activity, thus indirectly affecting its function in cellular signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 inhibits PC-PLD2C by targeting phosphoinositide 3-kinase (PI3K), a key regulator of PLD activity, thus indirectly impacting its function in cellular signaling pathways.